Alzheimer's drug Dimebon helps Huntington's - study

WASHINGTON Feb 8 (Reuters) - Dimebon, a pill being developed as a treatment for Alzheimer's disease, helped people with Huntington's disease improve their thinking, learning and memory skills, U.S. researchers said on Monday.

Dimebon, made by Medivation Inc (MDVN.O) under the generic name latrepirdine, appears to be safe for Huntington's patients and has minimal side effects, the researchers reported in the journal Archives of Neurology. (Reporting by JoAnne Allen; editing by Maggie Fox)